[tatsu_section bg_color= “” bg_image= “https://ax3325.p3cdn1.secureserver.net/wp-content/uploads/2020/03/641-1-1.jpg” bg_repeat= “no-repeat” bg_attachment= ‘{“d”:”scroll”}’ bg_position= ‘{“d”:”top left”}’ bg_size= ‘{“d”:”cover”}’ bg_animation= “none” padding= ‘{“d”:”120px 0px 120px 0px”}’ margin= ‘{“d”:”0px 0px 0px 0px”}’ bg_video_mp4_src= “” bg_video_ogg_src= “” bg_video_webm_src= “” overlay_color= “rgba(83,157,194,0.73)” overlay_blend_mode= “lighten” section_height_type= “auto” custom_height= ‘{“d”:””}’ vertical_align= “center” top_divider= “none” top_divider_zindex= “9999” bottom_divider_zindex= “9999” bottom_divider= “none” top_divider_height= ‘{“d”:”100″}’ top_divider_position= “above” bottom_divider_height= ‘{“d”:”100″}’ bottom_divider_position= “below” top_divider_color= “#ffffff” bottom_divider_color= “#ffffff” invert_top_divider= “0” invert_bottom_divider= “0” flip_top_divider= “0” flip_bottom_divider= “0” section_id= “” section_class= “” section_title= “” offset_value= “0px” full_screen_header_scheme= “background–dark” overflow= “” z_index= “0” hide_in= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:””}’ border_color= “” border_radius= “” box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” key= “51tE0ZbeGt”][tatsu_row full_width= “0” bg_color= “” border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:””}’ border_color= “” no_margin_bottom= “0” equal_height_columns= “0” gutter= “medium” column_spacing= “px” fullscreen_cols= “0” swap_cols= “0” padding= ‘{“d”:”0px 0px 0px 0px”}’ margin= ‘{“d”:”0px 0px”}’ row_id= “” row_class= “” box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” border_radius= “0” hide_in= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” layout= “1/1” key= “Oy0uhuXT6w”][tatsu_column bg_color= “” bg_image= “” bg_repeat= “no-repeat” bg_attachment= “scroll” bg_position= ‘{“d”:”top left”}’ bg_size= ‘{“d”:”cover”}’ padding= ‘{“d”:”0px 0px 0px 0px”}’ margin= ‘{“d”:””}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:””}’ border_color= “” border_radius= “0” box_shadow_custom= “0px 0px 0px 0px rgba(0,0,0,0)” bg_video_mp4_src= “” bg_video_ogg_src= “” bg_video_webm_src= “” overlay_color= “” overlay_blend_mode= “normal” animate_overlay= “none” link_overlay= “” vertical_align= “none” sticky= “0” offset= ‘{“d”:”0px 0px”}’ column_parallax= “0” column_width= ‘{“d”:100,”l”:100,”t”:100,”m”:100}’ column_mobile_spacing= “0” image_hover_effect= “none” column_hover_effect= “none” hover_box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” overflow= “” col_id= “” column_class= “” top_divider= “none” top_divider_height= ‘{“d”:”100″,”m”:”0″}’ top_divider_color= “#ffffff” flip_top_divider= “0” top_divider_zindex= “9999” bottom_divider= “none” bottom_divider_height= ‘{“d”:”100″,”m”:”0″}’ bottom_divider_color= “#ffffff” flip_bottom_divider= “0” bottom_divider_zindex= “9999” left_divider= “none” left_divider_width= ‘{“d”:”50″,”m”:”0″}’ left_divider_color= “#ffffff” invert_left_divider= “0” left_divider_zindex= “9999” right_divider= “none” right_divider_width= ‘{“d”:”50″,”m”:”0″}’ right_divider_color= “#ffffff” invert_right_divider= “0” right_divider_zindex= “9999” z_index= “0” hide_in= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” layout= “1/1” key= “l2JTlwC0M”][tatsu_text bg_color= “” color= “rgba(255,255,255,1)” max_width= ‘{“d”:”100″}’ wrap_alignment= “center” text_alignment= ‘{“d”:”left”}’ margin= ‘{“d”:”0px 0px 30px 0px”}’ box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” padding= ‘{“d”:”0px 0px 0px 0px”}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:”0px 0px 0px 0px”}’ border_color= “” border_radius= “0px” text_typography= ‘{“d”:””}’ hide_in= “” css_id= “” css_classes= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” key= “L3OuuxYbE”]
Case Studies & Method Reports
[/tatsu_text][tatsu_text bg_color= “” color= “rgba(255,255,255,1)” max_width= ‘{“d”:”100″}’ wrap_alignment= “center” text_alignment= ‘{“d”:”left”}’ margin= ‘{“d”:”0px 0px 30px 0px”}’ box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” padding= ‘{“d”:”0px 0px 0px 0px”}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:”0px 0px 0px 0px”}’ border_color= “” border_radius= “0px” text_typography= ‘{“d”:””}’ hide_in= “” css_id= “” css_classes= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” key= “F2GFQYaia”]
Come see why we’re excited about what we do and the future of AI-enabled drug development!
[/tatsu_text][/tatsu_column][/tatsu_row][/tatsu_section][tatsu_section bg_color= “” bg_image= “” bg_repeat= “no-repeat” bg_attachment= ‘{“d”:”scroll”}’ bg_position= ‘{“d”:”top left”}’ bg_size= ‘{“d”:”cover”}’ bg_animation= “none” padding= ‘{“d”:”90px 0px 90px 0px”}’ margin= ‘{“d”:”0px 0px 0px 0px”}’ bg_video_mp4_src= “” bg_video_ogg_src= “” bg_video_webm_src= “” overlay_color= “” overlay_blend_mode= “normal” section_height_type= “auto” custom_height= ‘{“d”:””}’ vertical_align= “center” top_divider= “none” top_divider_zindex= “9999” bottom_divider_zindex= “9999” bottom_divider= “none” top_divider_height= ‘{“d”:”100″}’ top_divider_position= “above” bottom_divider_height= ‘{“d”:”100″}’ bottom_divider_position= “below” top_divider_color= “#ffffff” bottom_divider_color= “#ffffff” invert_top_divider= “0” invert_bottom_divider= “0” flip_top_divider= “0” flip_bottom_divider= “0” section_id= “” section_class= “” section_title= “” offset_value= “0px” full_screen_header_scheme= “background–dark” overflow= “” z_index= “0” hide_in= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:””}’ border_color= “” border_radius= “” box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” key= “s-Q68vSKJe”][tatsu_row full_width= “0” bg_color= “” border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:””}’ border_color= “” no_margin_bottom= “0” equal_height_columns= “0” gutter= “medium” column_spacing= “px” fullscreen_cols= “0” swap_cols= “0” padding= ‘{“d”:”0px 0px 0px 0px”}’ margin= ‘{“d”:”0px 0px”}’ row_id= “” row_class= “” box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” border_radius= “0” hide_in= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” layout= “1/1” key= “Ntygt6_CgA”][tatsu_column bg_color= “” bg_image= “” bg_repeat= “no-repeat” bg_attachment= “scroll” bg_position= ‘{“d”:”top left”}’ bg_size= ‘{“d”:”cover”}’ padding= ‘{“d”:”0px 0px 0px 0px”}’ margin= ‘{“d”:””}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:””}’ border_color= “” border_radius= “0” box_shadow_custom= “0px 0px 0px 0px rgba(0,0,0,0)” bg_video_mp4_src= “” bg_video_ogg_src= “” bg_video_webm_src= “” overlay_color= “” overlay_blend_mode= “normal” animate_overlay= “none” link_overlay= “” vertical_align= “none” sticky= “0” offset= ‘{“d”:”0px 0px”}’ column_parallax= “0” column_width= ‘{“d”:100,”l”:100,”t”:100,”m”:100}’ column_mobile_spacing= “0” image_hover_effect= “none” column_hover_effect= “none” hover_box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” overflow= “” col_id= “” column_class= “” top_divider= “none” top_divider_height= ‘{“d”:”100″,”m”:”0″}’ top_divider_color= “#ffffff” flip_top_divider= “0” top_divider_zindex= “9999” bottom_divider= “none” bottom_divider_height= ‘{“d”:”100″,”m”:”0″}’ bottom_divider_color= “#ffffff” flip_bottom_divider= “0” bottom_divider_zindex= “9999” left_divider= “none” left_divider_width= ‘{“d”:”50″,”m”:”0″}’ left_divider_color= “#ffffff” invert_left_divider= “0” left_divider_zindex= “9999” right_divider= “none” right_divider_width= ‘{“d”:”50″,”m”:”0″}’ right_divider_color= “#ffffff” invert_right_divider= “0” right_divider_zindex= “9999” z_index= “0” hide_in= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” layout= “1/1” key= “K2xZjpyfO”][tatsu_title_icon icon= “” size= “large” alignment= “left” style= “plain” icon_bg= “” icon_color= ‘{“id”:”palette:0″,”color”:”#000000″}’ box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” outer_box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” icon_border_color= ‘{“id”:”palette:0″,”color”:”#000000″}’ hide_in= “” css_id= “” css_classes= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” padding= ‘{“d”:””,”m”:”0 0 0 0px”}’ margin= ‘{“d”:””}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:””}’ border_color= “” border_radius= “” key= “vKNvgn0kR”]
Finding the right patients, analogs, and indications for ONC201
ONC201 was a first-in-class anticancer compound in Phase II clinical trials, however its binding target and mechanism of action were unknown, which made future development and therapeutic positioning difficult. Our platform integrated data on ONC201’s structure, efficacy, and genomic effects to identify and validate its mechanism of action. Based on the identified binding target, we ranked other imipridone analogs based on predicted selectivity and efficacy, and identified the optimal cancer subtypes for Oncoceutics to pursue clinically. These predictions were validated in vitro, in vivo, and through clinical trials.
[/tatsu_title_icon][tatsu_gradient_button button_text= “Learn more” url= “https://onethree.bio/?p=5373” new_tab= “0” type= “large” alignment= “center” bg_color= ‘{“id”:”palette:3″,”color”:”rgba(82,81,116,1)”}’ hover_bg_color= ‘{“id”:”palette:1″,”color”:”rgba(253,253,253,1)”}’ color= ‘{“id”:”palette:1″,”color”:”#ffffff”}’ hover_color= ‘{“id”:”palette:0″,”color”:”rgba(65,129,161,1)”}’ border_width= “1” border_color= ‘{“id”:”palette:3″,”color”:”rgba(82,81,116,1)”}’ hover_border_color= ‘{“id”:”palette:0″,”color”:”rgba(65,129,161,1)”}’ lightbox= “0” image= “” video_url= “” hover_effect= “none” margin= ‘{“d”:”0px 0px 30px 0px”}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:”0px 0px 0px 0px”}’ outer_border_color= “” box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” hover_box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” hide_in= “” css_id= “” css_classes= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” padding= ‘{“d”:””}’ border_radius= “” key= “NGXN0RhzG”][/tatsu_gradient_button][tatsu_divider height= ‘{“d”:”1″}’ width= ‘{“d”:”100″}’ alignment= “left” color= “#efefef” margin= ‘{“d”:”0px 0px 20px 0px”}’ hide_in= “” css_id= “” css_classes= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” padding= ‘{“d”:””}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:””}’ border_color= “” border_radius= “” box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” key= “kNoLZvsRd”][/tatsu_divider][tatsu_title_icon icon= “” size= “large” alignment= “left” style= “plain” icon_bg= “” icon_color= ‘{“id”:”palette:0″,”color”:”#000000″}’ box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” outer_box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” icon_border_color= ‘{“id”:”palette:0″,”color”:”#000000″}’ hide_in= “” css_id= “” css_classes= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” padding= ‘{“d”:””}’ margin= ‘{“d”:””}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:””}’ border_color= “” border_radius= “” key= “RZFXa_Co0”]
Discovery of Novel Microtubule Inhibitors for Resistant Cancers
ONC201 was a first-in-class anticancer compound in Phase II clinical trials, however its binding target and mechanism of action were unknown, which made future development and therapeutic positioning difficult. Our platform integrated data on ONC201’s structure, efficacy, and genomic effects to identify and validate its mechanism of action. Based on the identified binding target, we ranked other imipridone analogs based on predicted selectivity and efficacy, and identified the optimal cancer subtypes for Oncoceutics to pursue clinically. These predictions were validated in vitro, in vivo, and through clinical trials.
[/tatsu_title_icon][tatsu_gradient_button button_text= “learn more” url= “https://onethree.bio/?p=5375” new_tab= “0” type= “large” alignment= “center” bg_color= ‘{“id”:”palette:3″,”color”:”rgba(82,81,116,1)”}’ hover_bg_color= ‘{“id”:”palette:1″,”color”:”rgba(253,253,253,1)”}’ color= ‘{“id”:”palette:1″,”color”:”#ffffff”}’ hover_color= ‘{“id”:”palette:0″,”color”:”rgba(65,129,161,1)”}’ border_width= “1” border_color= ‘{“id”:”palette:3″,”color”:”rgba(82,81,116,1)”}’ hover_border_color= ‘{“id”:”palette:0″,”color”:”rgba(65,129,161,1)”}’ lightbox= “0” image= “” video_url= “” hover_effect= “none” margin= ‘{“d”:”0px 0px 30px 0px”}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:”0px 0px 0px 0px”}’ outer_border_color= “” box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” hover_box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” hide_in= “” css_id= “” css_classes= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” padding= ‘{“d”:””}’ border_radius= “” key= “gd3drb4xui3b0605”][/tatsu_gradient_button][tatsu_divider height= ‘{“d”:”1″}’ width= ‘{“d”:”100″}’ alignment= “left” color= “#efefef” margin= ‘{“d”:”0px 0px 20px 0px”}’ hide_in= “” css_id= “” css_classes= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” padding= ‘{“d”:””}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:””}’ border_color= “” border_radius= “” box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” key= “0UR_MxY0K”][/tatsu_divider][tatsu_title_icon icon= “” size= “large” alignment= “left” style= “plain” icon_bg= “” icon_color= ‘{“id”:”palette:0″,”color”:”#000000″}’ box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” outer_box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” icon_border_color= ‘{“id”:”palette:0″,”color”:”#000000″}’ hide_in= “” css_id= “” css_classes= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” padding= ‘{“d”:””}’ margin= ‘{“d”:””}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:””}’ border_color= “” border_radius= “” key= “Xm3D5_Ch2”]
Predicting Genotype Specific Synergistic Combinations
ONC201 was a first-in-class anticancer compound in Phase II clinical trials, however its binding target and mechanism of action were unknown, which made future development and therapeutic positioning difficult. Our platform integrated data on ONC201’s structure, efficacy, and genomic effects to identify and validate its mechanism of action. Based on the identified binding target, we ranked other imipridone analogs based on predicted selectivity and efficacy, and identified the optimal cancer subtypes for Oncoceutics to pursue clinically. These predictions were validated in vitro, in vivo, and through clinical trials.
[/tatsu_title_icon][tatsu_gradient_button button_text= “learn more” url= “https://onethree.bio/?p=5377” new_tab= “0” type= “large” alignment= “center” bg_color= ‘{“id”:”palette:3″,”color”:”rgba(82,81,116,1)”}’ hover_bg_color= ‘{“id”:”palette:1″,”color”:”rgba(253,253,253,1)”}’ color= ‘{“id”:”palette:1″,”color”:”#ffffff”}’ hover_color= ‘{“id”:”palette:0″,”color”:”rgba(65,129,161,1)”}’ border_width= “1” border_color= ‘{“id”:”palette:3″,”color”:”rgba(82,81,116,1)”}’ hover_border_color= ‘{“id”:”palette:0″,”color”:”rgba(65,129,161,1)”}’ lightbox= “0” image= “” video_url= “” hover_effect= “none” margin= ‘{“d”:”0px 0px 30px 0px”}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:”0px 0px 0px 0px”}’ outer_border_color= “” box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” hover_box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” hide_in= “” css_id= “” css_classes= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” padding= ‘{“d”:””}’ border_radius= “” key= “gd3drg44e64cpkra”][/tatsu_gradient_button][tatsu_divider height= ‘{“d”:”1″}’ width= ‘{“d”:”100″}’ alignment= “left” color= “#efefef” margin= ‘{“d”:”0px 0px 20px 0px”}’ hide_in= “” css_id= “” css_classes= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” padding= ‘{“d”:””}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:””}’ border_color= “” border_radius= “” box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” key= “zThilPgxp”][/tatsu_divider][tatsu_title_icon icon= “” size= “large” alignment= “left” style= “plain” icon_bg= “” icon_color= ‘{“id”:”palette:0″,”color”:”#000000″}’ box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” outer_box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” icon_border_color= ‘{“id”:”palette:0″,”color”:”#000000″}’ hide_in= “” css_id= “” css_classes= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” padding= ‘{“d”:””}’ margin= ‘{“d”:””}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:””}’ border_color= “” border_radius= “” key= “ddWoUrsyB”]
Discovery of Novel Microtubule Inhibitors for Resistant Cancers
ONC201 was a first-in-class anticancer compound in Phase II clinical trials, however its binding target and mechanism of action were unknown, which made future development and therapeutic positioning difficult. Our platform integrated data on ONC201’s structure, efficacy, and genomic effects to identify and validate its mechanism of action. Based on the identified binding target, we ranked other imipridone analogs based on predicted selectivity and efficacy, and identified the optimal cancer subtypes for Oncoceutics to pursue clinically. These predictions were validated in vitro, in vivo, and through clinical trials.
[/tatsu_title_icon][tatsu_gradient_button button_text= “learn more” url= “https://onethree.bio/?p=5379” new_tab= “0” type= “large” alignment= “center” bg_color= ‘{“id”:”palette:3″,”color”:”rgba(82,81,116,1)”}’ hover_bg_color= “rgba(255,255,255,1)” color= ‘{“id”:”palette:1″,”color”:”#ffffff”}’ hover_color= ‘{“id”:”palette:0″,”color”:”rgba(65,129,161,1)”}’ border_width= “1” border_color= ‘{“id”:”palette:3″,”color”:”rgba(82,81,116,1)”}’ hover_border_color= ‘{“id”:”palette:0″,”color”:”rgba(65,129,161,1)”}’ lightbox= “0” image= “” video_url= “” hover_effect= “none” margin= ‘{“d”:”0px 0px 10px 0px”}’ border_style= ‘{“d”:”solid”,”l”:”solid”,”t”:”solid”,”m”:”solid”}’ border= ‘{“d”:”0px 0px 0px 0px”}’ outer_border_color= “” box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” hover_box_shadow= “0px 0px 0px 0px rgba(0,0,0,0)” hide_in= “” css_id= “” css_classes= “” animate= “1” animation_type= “none” animation_delay= “0” animation_duration= “300” padding= ‘{“d”:””}’ border_radius= “” key= “bTT6dem8N”][/tatsu_gradient_button][/tatsu_column][/tatsu_row][/tatsu_section]